The Token Is Broken: Rethinking Patient Tokenization
Patient tokenization replaces personal identifiers with encrypted tokens to link healthcare records...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
Aiding the advancement of Alzheimer’s treatment
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Maternal mental health matters
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Using real-world data to justify coverage for digital health solutions
Today’s most innovative companies are leveraging digital health data solutions to deliver...
The Fight Continues: Battling the COVID Evolution
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...